DEA Administrative Law Judge John Mulrooney has canceled the first hearings on the proposal to reschedule cannabis to a Schedule III drug after a legal challenge from pro-reform witnesses, Marijuana Moment’s Kyle Jaeger reports, citing the ruling. Mulrooney rejected arguments from rescheduling proponents regarding how alleged improper communications and witness selection decisions by a DEA Administrator warranted the agency’s removal from the process. He did grant a request for leave to file an interlocutory appeal, canceling the planned January 21 hearing and staying the proceedings for at least three months. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), Canopy Growth (CGC), Cronos Group (CRON), Green Thumb Industries (GTBIF), IGC Pharma (IGC), Tilray (TLRY), Trees Corporation (CANN) and Trulieve Cannabis (TCNNF).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACB:
- Rising High: Innovative Industrial reports PharmaCann default
- Rising High: Exclusive talk with biopharma company HMNC Brain Health
- Aurora Cannabis signs distribution partnership for its Australia subsidiary
- Rising High: Organigram acquires Motif Labs for C$90M upfront
- Aurora Cannabis initiated with a Buy at TD Securities